Ritholtz Wealth Management Cuts Position in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Ritholtz Wealth Management lessened its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 4.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,704 shares of the company’s stock after selling 826 shares during the quarter. Ritholtz Wealth Management’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $466,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Fifth Third Bancorp increased its holdings in Fresenius Medical Care AG & Co. KGaA by 3,654.9% during the 1st quarter. Fifth Third Bancorp now owns 7,660 shares of the company’s stock valued at $191,000 after acquiring an additional 7,456 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Fresenius Medical Care AG & Co. KGaA by 34.0% in the first quarter. GAMMA Investing LLC now owns 9,603 shares of the company’s stock valued at $239,000 after purchasing an additional 2,439 shares during the last quarter. Summit Global Investments acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the first quarter valued at approximately $1,443,000. Versant Capital Management Inc grew its position in shares of Fresenius Medical Care AG & Co. KGaA by 1,410.9% in the first quarter. Versant Capital Management Inc now owns 6,648 shares of the company’s stock valued at $166,000 after purchasing an additional 6,208 shares during the last quarter. Finally, Forum Financial Management LP acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the fourth quarter valued at approximately $247,000. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on FMS shares. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Thursday, May 15th. Truist Financial increased their price target on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $30.00 and gave the company a “hold” rating in a research report on Monday, May 12th. Finally, Wall Street Zen started coverage on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, May 20th. They issued a “strong-buy” rating on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating, one has given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $27.80.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Shares of NYSE FMS opened at $26.89 on Friday. Fresenius Medical Care AG & Co. KGaA has a 1 year low of $17.93 and a 1 year high of $30.46. The firm’s 50 day moving average price is $27.13 and its 200 day moving average price is $24.86. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.08 and a current ratio of 1.46.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.18% and a return on equity of 6.25%. The firm had revenue of $5.54 billion for the quarter, compared to analyst estimates of $4.71 billion. Equities analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The company also recently announced an annual dividend, which was paid on Friday, June 6th. Investors of record on Friday, May 23rd were given a dividend of $0.7871 per share. The ex-dividend date of this dividend was Friday, May 23rd. This represents a yield of 1.9%. This is a positive change from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.44. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is 50.89%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.